Association of gene polymorphisms in prolactin and its receptor with breast cancer risk in Taiwanese women

被引:0
作者
Fan-Yun Mong
Yu-Liang Kuo
Ching-Wen Liu
Wen-Sheng Liu
Li-Ching Chang
机构
[1] ZuoYing Armed Forces General Hospital,Division of General Surgery, Department of Surgery
[2] Chung Shan Medical University,School of Medical Imaging and Radiological Sciences
[3] Chung Shan Medical University Hospital,Department of Medical Imaging
[4] I-Shou University,Institute of Biotechnology and Chemical Engineering
[5] Asia-Pacific Biotech Developing,Department of Occupational Therapy
[6] Inc.,undefined
[7] I-Shou University,undefined
来源
Molecular Biology Reports | 2011年 / 38卷
关键词
Prolactin; Prolactin receptor; SNP; Breast cancer;
D O I
暂无
中图分类号
学科分类号
摘要
Given the essential role of prolactin (PRL) and its receptor (PRLR) in breast tumorigenesis, we investigated whether single nucleotide polymorphisms (SNPs) in the PRL and PRLR genes were associated with breast cancer in Taiwanese women. A total of 160 breast cancer patients and 336 unrelated control Taiwanese women were enrolled in this study. Three SNPs (rs1341238, rs2244502 and rs3756824) in the PRL gene and one SNP (rs10941235) in the PRLR gene were genotyped using allele-specific polymerase chain reaction and DNA sequencing. We showed that the PRLR SNP rs10941235 was associated with breast cancer (P < 0.05) and its genotype frequencies in the breast cancer group were significantly associated (P < 0.05) with the levels of cancer antigen 15-3, a serum biomarker of breast cancer. The PRL SNP rs3756824 was significantly associated with breast cancer metastasis (P < 0.05). These findings suggest that the polymorphism rs10941235 in the PRLR gene is associated with breast cancer and cancer antigen 15-3 levels in Taiwanese women.
引用
收藏
页码:4629 / 4636
页数:7
相关论文
共 94 条
[1]  
Freeman ME(2000)Prolactin: structure, function, and regulation of secretion Physiol Rev 80 1523-1631
[2]  
Kanyicska B(1997)Expression of the prolactin gene in normal and neoplastic human breast tissues and human mammary cell lines: promoter usage and alternative mRNA splicing Breast Cancer Res Treat 44 243-253
[3]  
Lerant A(1999)Prolactin involvement in breast cancer Endocr Relat Cancer 6 389-404
[4]  
Shaw-Bruha CM(1996)Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects Endocr Rev 17 639-669
[5]  
Pirrucello SJ(2002)Prolactin as an autocrine/paracrine growth factor in human cancer Trends Endocrinol Metab 13 245-250
[6]  
Shull JD(2003)The role of prolactin in mammary carcinoma Endocr Rev 24 1-27
[7]  
Vonderhaar BK(2007)A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort BMC Med Genet 8 72-86
[8]  
Ben-Jonathan N(1999)Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women J Natl Cancer Inst 91 629-634
[9]  
Mershon JL(1995)Serum prolactin levels and their relationship to survival in women with operable breast cancer J Clin Epidemiol 48 959-968
[10]  
Allen DL(2003)Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden) Cancer Causes Control 14 599-607